{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T21:49:35Z","timestamp":1789681775881,"version":"4.0.1"},"reference-count":88,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2017.00293","type":"journal-article","created":{"date-parts":[[2017,5,23]],"date-time":"2017-05-23T00:00:44Z","timestamp":1495497644000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":68,"title":["A Brief History of IL-1 and IL-1 Ra in Rheumatology"],"prefix":"10.3389","volume":"8","author":[{"given":"Jean-Michel","family":"Dayer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Oliviero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Punzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,5,23]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.4049\/jimmunol.123.6.2928","article-title":"Revised nomenclature for antigen nonspecific T cell proliferation and helper factors (letter to the Editor).","volume":"123","author":"Aarden","year":"1979","journal-title":"J. Immunol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1056\/NEJMoa0807865","article-title":"An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist.","volume":"360","author":"Aksentijevich","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"B3","doi-asserted-by":"crossref","first-page":"3868","DOI":"10.4049\/jimmunol.134.6.3868","article-title":"Effects of immune complexes on production by human monocytes of interleukin 1 or an interleukin 1 inhibitor.","volume":"134","author":"Arend","year":"1985","journal-title":"J. Immunol."},{"key":"B4","article-title":"Identification of interleukin 1-like activity and inhibitor(s) in urine from a patient with acute monoblastic leukemia.","volume":"3","author":"Balavoine","year":"1984","journal-title":"Lymphokine Res."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1172\/JCI112669","article-title":"Prostaglandin E2 and collagenase production by fibroblasts and synovial cells is regulated by urine-derived human interleukin 1 and inhibitor(s).","volume":"78","author":"Balavoine","year":"1986","journal-title":"J. Clin. Invest."},{"key":"B6","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/324263a0","article-title":"Identification of a common class of high affinity receptors for both types of porcine interleukin-1 on connective tissue cells.","volume":"324","author":"Bird","year":"1986","journal-title":"Nature"},{"key":"B7","doi-asserted-by":"crossref","first-page":"5323","DOI":"10.1016\/S0021-9258(18)83546-3","article-title":"A pre-aspartate-specific protease from human leukocytes that cleaves pro-interleukin-1 beta.","volume":"264","author":"Black","year":"1989","journal-title":"J. Biol. Chem."},{"key":"B8","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1002\/art.27290","article-title":"The role of synovial macrophages and macrophage-produced mediators in driving inflammatory and destructive responses in osteoarthritis.","volume":"62","author":"Bondeson","year":"2010","journal-title":"Arthritis Rheum."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1186\/ar2099","article-title":"The role of synovial macrophages and macrophage-produced cytokines in driving aggrecanases, matrix metalloproteinases, and other destructive and inflammatory responses in osteoarthritis.","volume":"8","author":"Bondeson","year":"2006","journal-title":"Arthritis Res. Ther."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.autrev.2014.08.008","article-title":"Effectiveness and tuberculosis-related safety profile of interleukin-1 blocking agents in the management of Beh\u00e7et\u2019s disease.","volume":"14","author":"Cantarini","year":"2015","journal-title":"Autoimmun. Rev."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1093\/rheumatology\/kev269","article-title":"Treating rheumatological diseases and co-morbidities with interleukin-1 blocking therapies.","volume":"54","author":"Cavalli","year":"2015","journal-title":"Rheumatology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1126\/science.1373520","article-title":"Molecular cloning of the interleukin-1 beta-converting enzyme.","volume":"256","author":"Cerretti","year":"1992","journal-title":"Science"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1172\/JCI28075","article-title":"MyD88-dependent IL-1 receptor signaling is essential for gouty inflammation stimulated by monosodium urate crystals.","volume":"116","author":"Chen","year":"2006","journal-title":"J. Clin. Invest."},{"key":"B14","doi-asserted-by":"publisher","first-page":"3452","DOI":"10.1002\/art.11355","article-title":"Gene deletion of either interleukin-1, interleukin-1-converting enzyme, inducible nitric oxide synthase, or stromelysin 1 accelerates the development of knee osteoarthritis in mice after surgical transection of the medial collateral ligament and partial medial meniscectomy.","volume":"48","author":"Clements","year":"2003","journal-title":"Arthritis Rheum."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-016-1156-1","article-title":"Rheumatoid synovial fibroblasts differentiate into distinct subsets in the presence of cytokines and cartilage.","volume":"18","author":"Croft","year":"2016","journal-title":"Arthritis Res. Ther."},{"key":"B16","article-title":"\u201cCollagenase- and PGE2-stimulating activity (interleukin-1-like) and inhibitor in urine from a patient with monocytic leukemia,\u201d","author":"Dayer","year":"1985","journal-title":"The Physiologic, Metabolic, and Immunologic Actions of Interleukin-1. Progress in Leukocyte Biology"},{"key":"B17","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.berh.2003.09.009","article-title":"The process of identifying and understanding cytokines: from basic studies to treating rheumatic diseases.","volume":"18","author":"Dayer","year":"2004","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1084\/jem.162.6.2163","article-title":"Cachectin\/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts.","volume":"162","author":"Dayer","year":"1985","journal-title":"J. Exp. Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1002\/art.10168","article-title":"Targeting interleukin-1 in the treatment of rheumatoid arthritis.","volume":"46","author":"Dayer","year":"2002","journal-title":"Arthritis Rheum."},{"key":"B20","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1172\/JCI109596","article-title":"Participation of monocyte-macrophages and lymphocytes in the production of a factor that stimulates collagenase and prostaglandin release by rheumatoid synovial cells.","volume":"64","author":"Dayer","year":"","journal-title":"J. Clin. Invest."},{"key":"B21","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1172\/JCI112350","article-title":"Human recombinant interleukin 1 stimulates collagenase and prostaglandin E2 production by human synovial cells.","volume":"77","author":"Dayer","year":"1986","journal-title":"J. Clin. Invest."},{"key":"B22","first-page":"329","article-title":"Collagenase and prostaglandin in connective tissue destruction: cell-cell and humoral interactions.","volume":"35","author":"Dayer","year":"","journal-title":"Bull. Schweiz. Akad. Med. Wiss."},{"key":"B23","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1126\/science.188134","article-title":"Collagenase production by rheumatoid synovial cells: stimulation by a human lymphocyte factor.","volume":"195","author":"Dayer","year":"","journal-title":"Science"},{"key":"B24","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1073\/pnas.73.3.945","article-title":"Production of collagenase and prostaglandins by isolated adherent rheumatoid synovial cells.","volume":"73","author":"Dayer","year":"1976","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B25","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1084\/jem.145.5.1399","article-title":"Prostaglandin production by rheumatoid synovial cells: stimulation by a factor from human mononuclear cells.","volume":"145","author":"Dayer","year":"","journal-title":"J. Exp. Med."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(81)80149-4","article-title":"Purification of a factor from human blood monocyte-macrophages which stimulates the production of collagenase and prostaglandin E2 by cells cultured from rheumatoid synovial tissues.","volume":"124","author":"Dayer","year":"1981","journal-title":"FEBS Lett."},{"key":"B27","doi-asserted-by":"crossref","DOI":"10.1142\/9789813207554_0006","article-title":"\u201cMMPs and cytokines in rheumatology,\u201d","author":"Dayer","year":"2017","journal-title":"Matrix Metalloproteinases in Health and Disease"},{"key":"B28","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1038\/ni.3503","article-title":"Interleukin 1\u03b1 and the inflammatory process.","volume":"17","author":"Di Paolo","year":"2016","journal-title":"Nat. Immunol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1002\/eji.201040319","article-title":"IL-1: discoveries, controversies and future directions.","volume":"40","author":"Dinarello","year":"2010","journal-title":"Eur. J. Immunol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1080\/23328940.2015.1017086","article-title":"The history of fever, leukocytic pyrogen and interleukin-1.","volume":"2","author":"Dinarello","year":"2015","journal-title":"Temperature"},{"key":"B31","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.smim.2013.10.008","article-title":"Treating inflammation by blocking interleukin-1 in humans.","volume":"25","author":"Dinarello","year":"2013","journal-title":"Semin. Immunol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1042\/bj1840177","article-title":"A cartilage catabolic factor from synovium.","volume":"184","author":"Dingle","year":"1979","journal-title":"Biochem. J."},{"key":"B33","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1084\/jem.162.2.501","article-title":"Detection and characterization of high affinity plasma membrane receptors for human interleukin 1.","volume":"162","author":"Dower","year":"1985","journal-title":"J. Exp. Med."},{"key":"B34","first-page":"234","article-title":"The fever of gout: urate crystals activate endogenous pyrogen production from human and rabbit mononuclear phagocytes.","volume":"96","author":"Duff","year":"1983","journal-title":"Trans. Assoc. Am. Physicians"},{"key":"B35","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/0014-5793(90)80106-S","article-title":"Identification of an interleukin-1 beta binding protein in human plasma.","volume":"260","author":"Eastgate","year":"1990","journal-title":"FEBS Lett."},{"key":"B36","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4159\/9780674972506-005","article-title":"\u201cEvolution of message discovery: the interleukin-1 family,\u201d","author":"Fantuzzi","year":"2016","journal-title":"Body Messages: The Quest for the Proteins of Cellular Communication"},{"key":"B37","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1136\/ard.52.12.870","article-title":"Cytokine expression in synovial membranes of patients with rheumatoid arthritis and osteoarthritis.","volume":"52","author":"Farahat","year":"1993","journal-title":"Ann. Rheum. Dis."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/S0002-9440(10)65368-0","article-title":"In vivo transfer of interleukin-1 receptor antagonist gene in osteoarthritic rabbit knee joints: prevention of osteoarthritis progression.","volume":"154","author":"Fernandes","year":"1999","journal-title":"Am. J. Pathol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1517\/14712598.1.2.301","article-title":"Interleukin-1 receptor antagonist as therapy for inflammatory disorders.","volume":"1","author":"Freeman","year":"2001","journal-title":"Expert Opin. Biol. Ther."},{"key":"B40","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/ng0997-25","article-title":"A candidate gene for familial Mediterranean fever.","volume":"17","year":"1997","journal-title":"Nat. Genet."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/j.immuni.2013.11.010","article-title":"The interleukin-1 family: back to the future.","volume":"39","author":"Garlanda","year":"2013","journal-title":"Immunity"},{"key":"B42","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1136\/ard.2007.082222","article-title":"Crystals of monosodium urate monohydrate enhance lipopolysaccharide-induced release of interleukin 1 beta by mononuclear cells through a caspase 1-mediated process.","volume":"68","author":"Giamarellos-Bourboulis","year":"2009","journal-title":"Ann. Rheum. Dis."},{"key":"B43","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/306378a0","article-title":"An interleukin 1 like factor stimulates bone resorption in vitro.","volume":"306","author":"Gowen","year":"1983","journal-title":"Nature"},{"key":"B44","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/ng756","article-title":"Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome.","volume":"29","author":"Hoffman","year":"2001","journal-title":"Nat. Genet."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1136\/annrheumdis-2014-206966","article-title":"Alpha-1-anti-trypsin-Fc fusion protein ameliorates gouty arthritis by reducing release and extracellular processing of IL-1\u03b2 and by the induction of endogenous IL-1Ra.","volume":"75","author":"Joosten","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"B46","doi-asserted-by":"publisher","first-page":"3237","DOI":"10.1002\/art.27667","article-title":"Engagement of fatty acids with Toll-like receptor 2 drives interleukin-1\u03b2 production via the ASC\/caspase 1 pathway in monosodium urate monohydrate crystal-induced gouty arthritis.","volume":"62","author":"Joosten","year":"2010","journal-title":"Arthritis Rheum."},{"key":"B47","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/nrrheum.2010.196","article-title":"Role of proinflammatory cytokines in the pathophysiology of osteoarthritis.","volume":"7","author":"Kapoor","year":"2011","journal-title":"Nat. Rev. Rheumatol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.joca.2010.12.003","article-title":"Large-scale meta-analysis of interleukin-1 beta and interleukin-1 receptor antagonist polymorphisms on risk of radiographic hip and knee osteoarthritis and severity of knee osteoarthritis.","volume":"19","author":"Kerkhof","year":"2011","journal-title":"Osteoarthritis Cartilage"},{"key":"B49","doi-asserted-by":"crossref","first-page":"4509","DOI":"10.4049\/jimmunol.136.12.4509","article-title":"Interleukin 1 alpha and interleukin 1 beta bind to the same receptor on T cells.","volume":"136","author":"Kilian","year":"1986","journal-title":"J. Immunol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/0014-5793(88)80797-X","article-title":"Two-chain structure of the interleukin 1 receptor.","volume":"229","author":"Kroggel","year":"1988","journal-title":"FEBS Lett."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.2337\/dc09-0533","article-title":"Sustained effects of interleukin-1 receptor antagonist treatment in type 2 diabetes.","volume":"32","author":"Larsen","year":"2009","journal-title":"Diabetes Care"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1002\/art.1780280911","article-title":"Crystal-induced endogenous pyrogen production. A further look at gouty inflammation.","volume":"28","author":"Malawista","year":"1985","journal-title":"Arthritis Rheum."},{"key":"B53","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1056\/NEJMoa1013068","article-title":"Interleukin-36-receptor antagonist deficiency and generalised pustular psoriasis.","volume":"365","author":"Marrakchi","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"B54","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S1097-2765(02)00599-3","article-title":"The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta.","volume":"10","author":"Martinon","year":"2002","journal-title":"Mol. Cell"},{"key":"B55","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nature04516","article-title":"Gout-associated uric acid crystals activate the NALP3 inflammasome.","volume":"440","author":"Martinon","year":"2006","journal-title":"Nature"},{"key":"B56","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1073\/pnas.78.4.2474","article-title":"Stimulation of rheumatoid synovial cell collagenase and prostaglandin production by partially purified lymphocyte-activating factor (interleukin 1).","volume":"78","author":"Mizel","year":"1981","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B57","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1002\/1529-0131(200011)43:11<2417::AID-ANR7>3.0.CO;2-R","article-title":"Association of genotypes affecting the expression of interleukin-1beta or interleukin-1 receptor antagonist with osteoarthritis.","volume":"43","author":"Moos","year":"2000","journal-title":"Arthritis Rheum."},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2350-11-50","article-title":"Allelic variants of IL1R1 gene associate with severe hand osteoarthritis.","volume":"11","author":"Nakki","year":"2010","journal-title":"BMC Med. Genet."},{"key":"B59","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1146\/annurev-immunol-032414-112306","article-title":"Inflammasome-independent regulation of IL-1-family cytokines.","volume":"33","author":"Netea","year":"2015","journal-title":"Annu. Rev. Immunol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/j.autrev.2012.07.024","article-title":"Specific interleukin-1 inhibitor in serum and urine of children with systemic juvenile chronic arthritis.","volume":"2","author":"Prieur","year":"1987","journal-title":"Lancet"},{"key":"B61","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.autrev.2012.07.024","article-title":"Gout as autoinflammatory disease: new mechanisms for more appropriated treatment targets.","volume":"12","author":"Punzi","year":"2012","journal-title":"Autoimmun. Rev."},{"key":"B62","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1185\/03007995.2013.790800","article-title":"Serum uric acid and gout: from the past to molecular biology.","author":"Punzi","year":"2013","journal-title":"Curr. Med. Res. Opin."},{"key":"B63","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1136\/annrheumdis-2016-210426","article-title":"CCL2\/CCR2, but not CCL5\/CCR5, mediates monocyte recruitment, inflammation and cartilage destruction in osteoarthritis.","volume":"76","author":"Raghu","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"B64","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1136\/annrheumdis-2016-209707","article-title":"2016 updated EULAR evidence-based recommendations for the management of gout.","volume":"76","author":"Richette","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"B65","doi-asserted-by":"crossref","first-page":"5485","DOI":"10.4049\/jimmunol.152.11.5485","article-title":"Crystal-induced neutrophil activation. V. Differential production of biologically active IL-1 and IL-1 receptor antagonist.","volume":"152","author":"Roberge","year":"1994","journal-title":"J. Immunol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/0006-291X(80)90082-0","article-title":"Identification of catabolin, a protein from synovium which induces degradation of cartilage in organ culture.","volume":"96","author":"Saklatvala","year":"1980","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B67","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1042\/bj2240461","article-title":"Pig catabolin is a form of interleukin 1. Cartilage and bone resorb, fibroblasts make prostaglandin and collagenase, and thymocyte proliferation is augmented in response to one protein.","volume":"224","author":"Saklatvala","year":"1984","journal-title":"Biochem. J."},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-014-0065-5","article-title":"Diverse expression of selected cytokines and proteinases in synovial fluid obtained from osteoarthritic and healthy human knee joints.","volume":"19","author":"Sauerschnig","year":"2014","journal-title":"Eur. J. Med. Res."},{"key":"B69","doi-asserted-by":"publisher","first-page":"384","DOI":"10.3109\/03009742.2015.1124452","article-title":"Synovial fluid proteins are required for the induction of interleukin-1\u03b2 production by monosodium urate crystals.","volume":"45","author":"Scanu","year":"2016","journal-title":"Scand. J. Rheumatol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.joca.2009.02.011","article-title":"Local cytokine profiles in knee osteoarthritis: elevated synovial fluid interleukin-15 differentiates early from end-stage disease.","volume":"17","author":"Scanzello","year":"2009","journal-title":"Osteoarthritis Cartilage"},{"key":"B71","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/nrrheum.2016.166","article-title":"Interleukin-1 function and role in rheumatic disease.","volume":"12","author":"Schett","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1136\/annrheumdis-2011-200908","article-title":"Canakinumab for acute gouty arthritis in patients with limited treatment options: results from two randomised, multicentre, active-controlled, double-blind trials and their initial extensions.","volume":"71","author":"Schlesinger","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"B73","doi-asserted-by":"crossref","first-page":"4181","DOI":"10.4049\/jimmunol.145.12.4181","article-title":"Natural and recombinant human IL-1 receptor antagonists block the effects of IL-1 on bone resorption and prostaglandin production.","volume":"145","author":"Seckinger","year":"1990","journal-title":"J. Immunol."},{"key":"B74","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.4049\/jimmunol.139.5.1546","article-title":"A urine inhibitor of interleukin 1 activity that blocks ligand binding.","volume":"139","author":"Seckinger","year":"","journal-title":"J. Immunol."},{"key":"B75","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.4049\/jimmunol.139.5.1541","article-title":"A urine inhibitor of interleukin 1 activity affects both interleukin 1 alpha and 1 beta but not tumor necrosis factor alpha.","volume":"139","author":"Seckinger","year":"","journal-title":"J. Immunol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1007\/s10067-016-3308-8","article-title":"Adult-onset Still\u2019s disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients.","volume":"35","author":"Sfriso","year":"2016","journal-title":"Clin. Rheumatol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1038\/nature01991","article-title":"Molecular identification of a danger signal that alerts the immune system to dying cells.","volume":"425","author":"Shi","year":"2003","journal-title":"Nature"},{"key":"B78","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1126\/science.2969618","article-title":"cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily.","volume":"241","author":"Sims","year":"1988","journal-title":"Science"},{"key":"B79","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/sj.gene.6364107","article-title":"Extended haplotypes and linkage disequilibrium in the IL1R1-IL1A-IL1B-IL1RN gene cluster: association with knee osteoarthritis.","volume":"5","author":"Smith","year":"2004","journal-title":"Genes Immun."},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1186\/ar2143","article-title":"A pilot study of IL-1 inhibition by anakinra in acute gout.","volume":"9","author":"So","year":"2007","journal-title":"Arthritis Res. Ther."},{"key":"B81","doi-asserted-by":"publisher","first-page":"21119","DOI":"10.1074\/jbc.C200179200","article-title":"The PYRIN-CARD protein ASC is an activating adaptor for caspase-1.","volume":"277","author":"Srinivasula","year":"2002","journal-title":"J. Biol. Chem."},{"key":"B82","doi-asserted-by":"crossref","first-page":"6141","DOI":"10.4049\/jimmunol.162.10.6141","article-title":"IL-1 Is an effective adjuvant for mucosal and systemic immune responses when coadministered with protein immunogens.","volume":"162","author":"Staats","year":"1999","journal-title":"J. Immunol."},{"key":"B83","doi-asserted-by":"crossref","first-page":"15836","DOI":"10.1016\/S0021-9258(19)49611-7","article-title":"Interleukin 1 induces NF-kappa B through its type I but not its type II receptor in lymphocytes.","volume":"267","author":"Stylianou","year":"1992","journal-title":"J. Biol. Chem."},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1186\/ar4159","article-title":"Rilonacept in the treatment of acute gouty arthritis: a randomized, controlled clinical trial using indomethacin as the active comparator.","volume":"15","author":"Terkeltaub","year":"2013","journal-title":"Arthritis Res. Ther."},{"key":"B85","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/S0960-9822(07)00352-1","article-title":"Identification of CARDIAK, a RIP-like kinase that associates with caspase-1.","volume":"8","author":"Thome","year":"1998","journal-title":"Curr. Biol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1038\/356768a0","article-title":"A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes.","volume":"356","author":"Thornberry","year":"1992","journal-title":"Nature"},{"key":"B87","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1002\/stem.140164","article-title":"Interleukin 1 trials in cancer patients: a review of the toxicity, antitumor and hematopoietic effects.","volume":"1","author":"Veltri","year":"1996","journal-title":"Oncologist"},{"key":"B88","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.orthres.2003.12.007","article-title":"Suppression of early experimental osteoarthritis by gene transfer of interleukin-1 receptor antagonist and interleukin-10.","volume":"22","author":"Zhang","year":"2004","journal-title":"J. Orthop. Res."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fphar.2017.00293\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T04:02:56Z","timestamp":1719201776000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fphar.2017.00293\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,23]]},"references-count":88,"alternative-id":["10.3389\/fphar.2017.00293"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2017.00293","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,23]]},"article-number":"293"}}